This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignees: Novartis Ag, Mitsubishi Pharma Corporation. Active years: 2012-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Edison, NJ (US) (2012)
- Mumbai, IN (2013)
Company Filing History:

Years Active: 2012-2013
Title: Innovations by Madhusudhan Pudipeddi
Introduction
Madhusudhan Pudipeddi is a notable inventor based in Mumbai, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid dosage forms. With a total of 2 patents to his name, his work has had a considerable impact on medication delivery systems.
Latest Patents
Madhusudhan's latest patents include innovative formulations that enhance the efficacy of various medications. One of his patents focuses on solid dosage forms of valsartan, amlodipine, and hydrochlorothiazide, detailing a method for creating monolayer, bilayer, and trilayer solid dosage forms. Another patent involves solid pharmaceutical compositions that comprise a SIP receptor agonist and a sugar alcohol, designed for oral administration.
Career Highlights
Throughout his career, Madhusudhan has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Mitsubishi Pharma Corporation. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in drug formulation.
Collaborations
Madhusudhan has collaborated with esteemed colleagues such as Alan Edward Royce and Yu Cao. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Madhusudhan Pudipeddi's contributions to pharmaceutical innovations demonstrate his commitment to improving medication delivery systems. His patents reflect a deep understanding of drug formulation, and his collaborations with industry leaders further enhance his impact in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile